High fracture risk: How to define, how to treat?

27.01.2017 High fracture risk: How to define, how to treat? Dr Emmanuel BIVER Department of Bone Diseases Geneva University Hospitals and Faculty of ...
Author: Marta Huber
25 downloads 1 Views 1MB Size
27.01.2017

High fracture risk: How to define, how to treat? Dr Emmanuel BIVER Department of Bone Diseases Geneva University Hospitals and Faculty of Medicine 8. Basler Fortbildung in praktischer Osteologie, Universitätsspital Basel, 26. Januar 2017

What is a high fracture risk?

Age BMD 7%

-2.5SD Need to take account of the BMD and its interaction with age

Kanis et al. Osteoporos Int 2001 Lippuner et al. Osteoporos Int 2009

1

27.01.2017

What is a high fracture risk?

Fracture site

Sambrook et al. Lancet 2006

Kanis et al. Osteoporos Int 2001

What is a high fracture risk?

Clinical risk factors

2

27.01.2017

Schweizerische Vereinigung gegen die Osteoporose: Empfehlungen 2015 Postmenopausale Frauen und Männer ab 60. Lebensjahr Allgemeine Risikofaktoren Wirbelfraktur(en) Nichtvertebrale Fraktur(en) nach dem 50. Lebensjahr (Ausnahme: Finger, Zehen, Schädel, Knöchel) Proximale Femurfraktur eines Elternteils Untergewicht (BMI 4) Moderat (RR= 1.5-2) Moderat (RR= 1.5-2) Schwer (RR= 2-4) Schwer (RR= 2-4)

 

Sehr schwer (RR >4) Schwer (RR= 2-4) Moderat (RR= 1.5-2) Moderat (RR= 1.5-2) Schwer (RR= 2-4) Schwer (RR= 2-4)

 



Prior fracture

“All fracture locations apart from rib (men) and ankle (women) resulted in increased subsequent fracture risk”

Center, JAMA. 2007;297:387-394

3

27.01.2017

GIOP Vertebral fracture rate (*per 100 person-years, with 95 % confidence intervals) by study length of follow-up among GC initiators (50 with osteoporosis and no recent fracture (not yet fracture), falls, older age, poorer health status, comorbidities, and other potential fall risk factors were predictive of imminent risk for fracture. Bonafede et al, Arch Osteoporos 2016

7

27.01.2017

Treatment: Key messages Exclusion of secondary causes of osteoporosis or other causes of bone fragility before pharmacological intervention.

- Regular physical activity - Prevention of falls - Correction of nutritional deficiencies, including vitamin D repletion - Pharmacological intervention.

Pharmacological intervention: Evidence base Medicine Drug

Alendronate

Bisphosphonates

Effect on fracture risk reduction demonstrated in clinical trials Vertebral Non-vertebral Hip + + +

Risedronate

+

+

+

Ibandronate

+

Post hoc



Zoledronate

+

+

+

Raloxifene

+

Post hoc



SERMs

Swissmedic indication

- Osteoporosis treatment - Prevention and treatment of osteoporosis - Osteoporosis treatment (to reduce vertebral fractures) - Osteoporosis treatment - Prevention of fracture after a hip fracture - Prevention and treatment of GIOP - Prevention and treatment of osteoporosis (to reduce vertebral fractures)

Bazedoxifene

+

Post hoc



Anti-RANKL monoclonal antibodies

Denosumab

+

+

+

- Osteoporosis treatment (to reduce vertebral and non-vertebral fractures)

Parathyroid hormone

Teriparatide

+

+



- Osteoporosis and GIOP treatment with high risk of fracture.

8

27.01.2017

Potential use of teriparatide as first-line treatment option Teriparatide (FOSTEO): reimbursed as second-line treatment in postmenopausal women and men with increased fracture risk, specifically in patients with incident fractures under antiresorptive therapy or patients with glucocorticoid-induced osteoporosis and intolerance to antiresorptives.

Meier et al, Swiss Med Wkly. 2014;144:w13952

Sequential therapy with teriparatide and antiresorptive drugs • Teriparatide  No treatment • Teriparatide  Bisphosphonate • Teriparatide  Denosumab • Bisphosphonate  Teriparatide • Denosumab  Teriparatide

x    x

9

27.01.2017

Abaloparatide: analog of PTHrp that selectively binds to the parathyroid hormone type 1

→ more pronounced anabolic action on bone compared with teriparatide?

Miller, JAMA. 2016;316(7):722-733.

Romosozumab: a monoclonal antibody that binds and inhibits sclerostin, a negative regulator of bone formation

→ increases bone formation and decreases bone resorption.

McClung. N Engl J Med. 2014

Cosman. N Engl J Med. 2016

10

27.01.2017

Take Home messages: High risk of fracture • Age, BMD, clinical risk factors…, falls… • Some clinical situations at particularly high risk of fracture: recent vertebral or hip fractures • Tools: DXA, FRAX • Imminent risk of fracture • Treatment: fall prevention + bone fragility treatment

11

Suggest Documents